PHUSIS: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
PHUSIS
Largest movements
- Receivables within one year -€132,570
down €132,570 (-63.7%), from €207,996 to €75,426
of which Trade receivables: -€153,936
- Current investments -€37,444
no longer reported in 2025 (was €37,444)
- Cash +€19,400
up €19,400 (+30.2%), from €64,143 to €83,542
mainly Receivables within one year (+€132,570) and Current investments (+€37,444)
- Trade debts -€66,298
down €66,298 (-95.3%), from €69,571 to €3,273
- Accrued charges and deferred income -€57,600
down €57,600 (-100.0%), from €57,600 to €0
- Tax, wage and social debts -€16,099
down €16,099 (-100.0%), from €16,099 to €0
- Profit (loss) carried forward -€8,848
down €8,848 (-12.5%), from -€70,752 to -€79,600
- Gross operating margin -€60,031
down €60,031, from €51,555 to -€8,476
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €311,219 | €162,387 | -€148,832 | -47.8% |
| Current assets | 29/58 | €311,219 | €162,387 | -€148,832 | -47.8% |
| Amounts receivable within one year | 40/41 | €207,996 | €75,426 | -€132,570 | -63.7% |
| Trade receivables | 40 | €201,996 | €48,060 | -€153,936 | -76.2% |
| Other amounts receivable | 41 | €6,000 | €27,366 | +€21,366 | +356.1% |
| Current investments | 50/53 | €37,444 | - | -€37,444 | |
| Cash at bank and in hand | 54/58 | €64,143 | €83,542 | +€19,400 | +30.2% |
| Deferred charges and accrued income | 490/1 | €1,636 | €3,419 | +€1,783 | +109.0% |
| Total equity and liabilities | 10/49 | €311,219 | €162,387 | -€148,832 | -47.8% |
| Equity | 10/15 | €165,507 | €156,659 | -€8,848 | -5.3% |
| Contributions | 10/11 | €43,100 | €43,100 | = | 0.0% |
| Reserves | 13 | €193,159 | €193,159 | = | 0.0% |
| Distributable reserves | 133 | €193,159 | €193,159 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€70,752 | -€79,600 | -€8,848 | -12.5% |
| Amounts payable | 17/49 | €145,712 | €5,728 | -€139,984 | -96.1% |
| Amounts payable within one year | 42/48 | €88,112 | €5,728 | -€82,384 | -93.5% |
| Financial debts | 43 | €303 | €317 | +€13 | +4.4% |
| Credit institutions | 430/8 | €303 | - | -€303 | |
| Other loans | 439 | - | €317 | +€317 | |
| Trade debts | 44 | €69,571 | €3,273 | -€66,298 | -95.3% |
| Suppliers | 440/4 | €69,571 | €3,273 | -€66,298 | -95.3% |
| Taxes, remuneration and social security | 45 | €16,099 | €0 | -€16,099 | -100.0% |
| Taxes | 450/3 | €16,099 | €0 | -€16,099 | -100.0% |
| Other amounts payable | 47/48 | €2,138 | €2,138 | = | 0.0% |
| Accrued charges and deferred income | 492/3 | €57,600 | €0 | -€57,600 | -100.0% |
| Other operating charges | 640/8 | €487 | €500 | +€12 | +2.5% |
| Gross operating margin | 9900 | €51,555 | -€8,476 | -€60,031 | |
| Operating profit (loss) | 9901 | €51,068 | -€8,976 | -€60,044 | |
| Financial income | 75/76B | €400 | €344 | -€56 | -13.9% |
| Recurring financial income | 75 | €400 | €344 | -€56 | -13.9% |
| Financial charges | 65/66B | €390 | €216 | -€174 | -44.7% |
| Recurring financial charges | 65 | €390 | €216 | -€174 | -44.7% |
| Profit (loss) for the period before taxes | 9903 | €51,077 | -€8,848 | -€59,925 | |
| Profit (loss) for the period | 9904 | €51,077 | -€8,848 | -€59,925 | |
| Profit (loss) for the period to be appropriated | 9905 | €51,077 | -€8,848 | -€59,925 |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 5 October 2026 via checked.be.